CALC CalciMedica, Inc.

NASDAQ
$1.19

CalciMedica, Inc. (CALC) is expected to report earnings on February 9, 2027, before the market open. The consensus earnings estimate is a loss of $0.41 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -21.2% since its last earnings release on November 10, 2026.

CalciMedica Beat Consensus Estimates
Tuesday, November 10, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 9
Tuesday · 7:00 AM ET
Earnings Whisper
-
vs ($0.41)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $1.23

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CalciMedica, Inc.

CalciMedica Inc. is a clinical-stage biopharmaceutical company. It focused on developing therapies for life-threatening inflammatory diseases with high unmet need. CalciMedica Inc. is based in LA JOLLA, Calif.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.